EUVIMEDEUVIMED entdecken
Crossref

Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City

Nancy Martinez-Rivera, Daniel Franco, Brenda L Acosta-Maldonado, Pamela Alatorre-Fernandez, Beda Islas-Muñoz, Carolina Perez-Jimenez, Alexandra Martin-Onraet iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Nancy Martinez-Rivera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Instituto Nacional de Cancerologia, Mexico City, Mexico. Hauptthemen laut MEDLINE: COVID-19, Hematopoietic Stem Cell Transplantation, SARS-CoV-2. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hematopoietic stem cell transplant (HSCT) recipients are among patients with highest risk of adverse coronavirus disease 2019 (COVID‐19) outcomes.

Objective

We compared clinical outcomes in post‐HSCT patients with COVID‐19 before and during the Omicron period. Study Design This was a retrospective study including patients post‐HSCT with severe acute respiratory syndrome coronavirus 2 infection from April 2020 to March 2023 at Instituto Nacional de Cancerología, Mexico City. We describe their clinical characteristics and report the variables associated with severe clinical disease, hospitalization, and death.

Results

Fifty‐three patients were included; 31 (58.5%) from the pre‐Omicron period and 22 (41.5%) from the Omicron period. Median age was 42‐years old (interquartile range 26–53), and 31 patients (59%) were men. Only four patients (16%) had received a vaccine prior to COVID‐19 diagnosis in the pre‐Omicron period versus 20 (91%) in the Omicron period ( p < 0.001). COVID‐19 severe cases were more common before Omicron: seven patients (23%) versus two patients (9%). Only one patient (3%) received an antiviral in the pre‐Omicron period compared to 11 patients (50%) during the Omicron period ( p < 0.01). COVID‐19‐associated mortality was almost double in the pre‐Omicron period (16% vs. 9%, p = 0.6).

Conclusions

This study reports patients with a high proportion of severe outcomes during the first 2 years of the pandemic. Outcomes improved during Omicron with better access to vaccines and antivirals and no in‐hospital cases. Variables associated with worse outcomes were similar to other reports. Strengthening infection control measures in the hospital and better access to preventive strategies and therapeutic options are mandatory in these high‐risk patients. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hematopoietic Stem Cell TransplantationSARS-CoV-2HumansMaleMexicoAdultMiddle AgedFemaleRetrospective StudiesHospitalizationTransplant RecipientsCOVID-19 Vaccines

Stichwörter der Autor:innen

COVID‐19COVID‐19 vaccinesSARS‐CoV‐2antiviralshematopoietic stem cell transplantation

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Infectious Diseases Department, Instituto Nacional de Cancerologia, Mexico City, Mexico.
  • Hematology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.

ORCID-Profile: Alexandra Martin-Onraet

Zitieren

APA

Martinez-Rivera, N., Franco, D., Acosta-Maldonado, B. L., Alatorre-Fernandez, P., Islas-Muñoz, B., Perez-Jimenez, C., & Martin-Onraet, A. (2024). Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City. Transplant Infectious Disease. https://doi.org/10.1111/tid.14274

Vancouver

Martinez-Rivera N, Franco D, Acosta-Maldonado BL, Alatorre-Fernandez P, Islas-Muñoz B, Perez-Jimenez C, et al. Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City. Transplant Infectious Disease. 2024. doi:10.1111/tid.14274

BibTeX
@article{MartinezRivera2024,
  author = {Martinez-Rivera, Nancy and Franco, Daniel and Acosta-Maldonado, Brenda L and Alatorre-Fernandez, Pamela and Islas-Muñoz, Beda and Perez-Jimenez, Carolina and Martin-Onraet, Alexandra},
  title = {Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14274}
}
Kostenlos starten →